10:15am ET
Health and Healthcare
Eli Lilly Receives Crucial FDA Update on Lupus Study
Eli Lilly shares rose slightly on Thursday after the company announced an FDA update on its treatment for systemic lupus erythematosus.
Chris Lange
Companies
/Healthcare
Lilly(Eli) & Company
$1,189.41
▼ $44.25 (−3.59%) today
Markets closed · 8:23pm ET
LLY Coverage
Page 23 Chris Lange 9:50am ET
Health and Healthcare
Major Pharma Stocks See a Surge in Short Interest
The November 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
9:00am ET
Health and Healthcare
Short Sellers Hike Their Bets in Major Pharma Stocks
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
8:40am ET
Investing
Top Analyst Upgrades and Downgrades: American Eagle, Eli Lilly, GameStop, Intuit, Novavax, Nvidia, Salesforce, Schlumberger and More
The top analyst upgrades, downgrades and initiations seen on Monday included American Eagle Outfitters, Eli Lilly, GameStop, Intuit, Novavax, Nvidia, Salesforce.com and Schlumberger.
10:10am ET
Investing
Short Sellers Pull Back on Major Pharma — With 1 Big Exception
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
12:45pm ET
Health and Healthcare
New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved
The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to help combat disease-related causes.
10:20am ET
Health and Healthcare
Eli Lilly Dips Despite Solid Q3 Results
Eli Lilly released better-than-expected third-quarter financial results before the markets opened on Tuesday.
Chris Lange 11:25am ET
Health and Healthcare
What to Watch For When Eli Lilly Reports Tuesday Morning
Eli Lilly is scheduled to release its most recent quarterly results before the markets open on Tuesday.
Chris Lange 9:05am ET
Investing
Top Analyst Upgrades and Downgrades: Aetna, Baker Hughes, Chesapeake Energy, Cognizant, Cummins, Eli Lilly, GE, Qualcomm, Weatherford and More
The top analyst upgrades, downgrades and initiations seen on Wednesday included Aetna, Baker Hughes, Chesapeake Energy, Cognizant Technology Solutions, Cummins, Eli Lilly, General Electric, Qualcomm and Weatherford.
9:45am ET
Health and Healthcare
Dicerna Pharma Teams Up With Eli Lilly for RNAi Technology
Dicerna Pharmaceuticals and Eli Lilly are partnering up in a global licensing and research collaboration focused on the discovery, development and commercialization of potential new medicines in the areas of cardio-metabolic disease,…
Chris Lange 9:00am ET
Health and Healthcare
Major Pharma Short Sellers Hike Their Bets
The October 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
9:10am ET
Health and Healthcare
Short Sellers Run for Cover From Major Pharma
The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo, Roku and More
The top analyst upgrades, downgrades and initiations seen on Friday included Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo and Roku.
8:50am ET
Health and Healthcare
Short Sellers Grow More Selective on Major Pharma Stocks
The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
7:20am ET
Investing
The Top IPOs From This Week
With the markets at all-time highs, it is prime season for initial public offerings and companies can get more bang for their buck. There were a couple major IPOs this week that…
Chris Lange